• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Value of Adherence


Darius Lakdawalla, PhD, addresses the value of diabetes patients' adherence in this clip.

Darius Lakdawalla, PhD, addresses the value of diabetes patients’ adherence in this clip. According to Dr Lakdawalla, diabetes patients account for about one-third of total Medicare spending. By 2050, that percentage could be one half of Medicare spending. Risk factors, including the rise of obesity in the population, are contributing to the increase of diabetes diagnoses.

To control rising costs, Dr Lakdawalla suggests interventions must be made, including biomedical innovation and technologies that can improve medication adherence. Improved adherence could be worth almost $13,000 per patient with diabetes


“Some payers have been reluctant to reimburse technologies that focus specifically on adherence and convenience and those kinds of outcomes,” says Dr Lakdawalla. “That's changing with the implementation of the ACA and other kinds of policies in which payers are taking a more holistic role in care. Those changes, I think, are to be encouraged.”

Related Videos
Chase D. Hendrickson, MD, MPH
Dr Jeffrey Sippel
Steven Coca, MD, MS, Icahn School of Medicine, Mount Sinai
Lalan Wilfongd, MD, US Oncology Network
Ben Urick, PharmD, PhD
Bincy Abraham, MD
Matthew Crowley, MD, MHS, associate professor of medicine, Duke University School of Medicine.
Susan Spratt, MD, senior medical director, Duke Population Health Management Office, associate professor of medicine, division of Endocrinology, Metabolism, and Nutrition,
Related Content
© 2023 MJH Life Sciences
All rights reserved.